Home    eJManager.com Add Your Journal   |    Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research

Vet World. 2010; 3(10): 466-468


Effect of PGF2 alpha on Oestrus and Fertility rate in repeat breeder cows treated with Norgestomet-Oestradiol

M. Selvaraju, C. Veerapandian.

Abstract
A total of 48 repeat breeder cows were equally divided in to two treatment groups as NOR and NOR-PG and were treated with norgestomet ear implants on day 10 following natural oestrus and a control group. At the time of ear implant insertion, 2 ml of SMB injection was administered intramuscularly to all the cows. The implant was removed after 9 days. Cows in NOR-PG group were injected with 0.98 mg of PGF2a at the time of implant removal. In NOR and NOR-PG groups, AI was done at 48 and 72 hours of implant withdrawal. In control group, cows were artificially inseminated twice at 24 hours interval during natural oestrus. Blood samples were collected at the time of implant insertion and withdrawal in all the treated cows for progesterone assay. There was 100 per cent oestrus response following implant removal in NOR and NOR-PG groups. The conception rate obtain in NOR, NOR-PG and control groups were 43.75, 37.50 and 18.75 per cent, respectively. The overall mean level of progesterone (6.31±0.32 ng/ml) noticed at the time of implant insertion was significantly reduced to a lower level (1.38±0.16 ng/ml) by the time of its removal in treated cows. It is inferred that norgestomet–oestradiol alone without PGF2a may be used to augment fertility in repeat breeder cows under field conditions.

Key words: PGF2 alpha, Oestrus, Norgestomet, Oestradiol, Fertility Rate, Repeat Breeder Cows.



Share this Article





ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMed® International Medical Journal Management and Indexing System.
Scopemed Buttons